Sign In

Login

Password

Forgot Password ? Sign Up

سورانيب (Arabic Wikipedia)

Analysis of information sources in references of the Wikipedia article "سورانيب" in Arabic language version.

refsWebsite
Global rank Arabic rank
7wikidata.org
43rd place
2nd place
5doi.org
2nd place
5th place
5nih.gov
4th place
6th place
2ncats.io
low place
3,760th place
2ebi.ac.uk
5,849th place
872nd place
2web.archive.org
1st place
1st place
1issn.org
57th place
1,629th place
1chemspider.com
8,573rd place
3,029th place
1fda.gov
447th place
393rd place

chemspider.com (Global: 8,573rd place; Arabic: 3,029th place)

doi.org (Global: 2nd place; Arabic: 5th place)

  • Simon Maskell; Munir Pirmohamed (4 Mar 2022). "A reference set of clinically relevant adverse drug-drug interactions". Scientific Data (بالإنجليزية). 9 (1). DOI:10.1038/S41597-022-01159-Y. ISSN:2052-4463. PMID:35246559. QID:Q123478206.
  • Drug Indications Extracted from FAERS، DOI:10.5281/ZENODO.1435999، QID:Q56863002
  • Wilhelm SM، Adnane L، Newell P، Villanueva A، Llovet JM، Lynch M (أكتوبر 2008). "Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling". Mol. Cancer Ther. ج. 7 ع. 10: 3129–40. DOI:10.1158/1535-7163.MCT-08-0013. PMID:18852116.
  • Smalley KS، Xiao M، Villanueva J، Nguyen TK، Flaherty KT، Letrero R، Van Belle P، Elder DE، Wang Y، Nathanson KL، Herlyn M (يناير 2009). "CRAF inhibition induces apoptosis in melanoma cells with non-V600E BRAF mutations". Oncogene. ج. 28 ع. 1: 85–94. DOI:10.1038/onc.2008.362. PMC:2898184. PMID:18794803.
  • . DOI:10.5281/ZENODO.1435999. {{استشهاد بمجلة}}: الاستشهاد ب$1 يطلب |$2= (مساعدة) والوسيط |title= غير موجود أو فارغ (مساعدة)

ebi.ac.uk (Global: 5,849th place; Arabic: 872nd place)

fda.gov (Global: 447th place; Arabic: 393rd place)

issn.org (Global: 57th place; Arabic: 1,629th place)

portal.issn.org

  • Simon Maskell; Munir Pirmohamed (4 Mar 2022). "A reference set of clinically relevant adverse drug-drug interactions". Scientific Data (بالإنجليزية). 9 (1). DOI:10.1038/S41597-022-01159-Y. ISSN:2052-4463. PMID:35246559. QID:Q123478206.

ncats.io (Global: low place; Arabic: 3,760th place)

drugs.ncats.io

nih.gov (Global: 4th place; Arabic: 6th place)

pubmed.ncbi.nlm.nih.gov

  • Simon Maskell; Munir Pirmohamed (4 Mar 2022). "A reference set of clinically relevant adverse drug-drug interactions". Scientific Data (بالإنجليزية). 9 (1). DOI:10.1038/S41597-022-01159-Y. ISSN:2052-4463. PMID:35246559. QID:Q123478206.
  • Wilhelm SM، Adnane L، Newell P، Villanueva A، Llovet JM، Lynch M (أكتوبر 2008). "Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling". Mol. Cancer Ther. ج. 7 ع. 10: 3129–40. DOI:10.1158/1535-7163.MCT-08-0013. PMID:18852116.
  • Smalley KS، Xiao M، Villanueva J، Nguyen TK، Flaherty KT، Letrero R، Van Belle P، Elder DE، Wang Y، Nathanson KL، Herlyn M (يناير 2009). "CRAF inhibition induces apoptosis in melanoma cells with non-V600E BRAF mutations". Oncogene. ج. 28 ع. 1: 85–94. DOI:10.1038/onc.2008.362. PMC:2898184. PMID:18794803.

pubchem.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

web.archive.org (Global: 1st place; Arabic: 1st place)

wikidata.org (Global: 43rd place; Arabic: 2nd place)

  • Simon Maskell; Munir Pirmohamed (4 Mar 2022). "A reference set of clinically relevant adverse drug-drug interactions". Scientific Data (بالإنجليزية). 9 (1). DOI:10.1038/S41597-022-01159-Y. ISSN:2052-4463. PMID:35246559. QID:Q123478206.
  • Drug Indications Extracted from FAERS، DOI:10.5281/ZENODO.1435999، QID:Q56863002
  • Inxight: Drugs Database، QID:Q57664317
  • Sorafenib (بالإنجليزية), QID:Q278487
  • Sorafenib، QID:Q2311683
  • Sorafenib، QID:Q6120337
  • SORAFENIB، QID:Q6120337